Beyond phage display: Non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold

Frontiers in Microbiology

Volumn 6, Issue AUG, 2015, Pages

  Henry, Kevin A ^a   Arbabi Ghahroudi, Mehdi ^a,b,c   Scott, Jamie K ^d  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c CARLETON UNIVERSITY   (Canada)

^d SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Antimicrobial; Bioconjugation; Filamentous phage; Therapeutic; Vaccine

Indexed keywords

COAT PROTEIN; DNA VACCINE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NANOMATERIAL; PEPTIDE VACCINE; RECOMBINANT PROTEIN; VACCINE;

ALZHEIMER DISEASE; B LYMPHOCYTE; BACTERIAL INFECTION; BACTERIOPHAGE; CHRONIC DISEASE; CONJUGATION; CYTOTOXIC T LYMPHOCYTE; ECOLOGY; ESCHERICHIA COLI; FILAMENTOUS BACTERIOPHAGE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; METAGENOMICS; NEOPLASM; NONHUMAN; PHAGE DISPLAY; PROPHYLAXIS; PROTEIN ENGINEERING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VACCINATION;

EID: 84941010079     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00755     Document Type: Review

References (245)

1. Abbineni, G., Modali, S., Safiejko-Mroczka, B., Petrenko, V. A., and Mao, C. (2010). Evolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization. Mol. Pharm. 7, 1629-1642. doi: 10.1021/mp100052y
2. Abdennebi, L., Couture, L., Grebert, D., Pajot, E., Salesse, R., and Remy, J. J. (1999). Generating FSH antagonists and agonists through immunization against FSH receptor N-terminal decapeptides. J. Mol. Endocrinol. 22, 151-159. doi: 10.1677/jme.0.0220151
3. Alhamlan, F. S., Ederer, M. M., Brown, C. J., Coats, E. R., and Crawford, R. L. (2013). Metagenomics-based analysis of viral communities in dairy lagoon wastewater. J. Microbiol. Methods 92, 183-188. doi: 10.1016/j.mimet.2012.11.016
4. Ashelford, K. E., Day, M. J., and Fry, J. C. (2003). Elevated abundance of bacteriophage infecting bacteria in soil. Appl. Environ. Microbiol. 69, 285-289. doi: 10.1128/AEM.69.1.285-289.2003
5. Bahadir, A. O., Balcioglu, B. K., Uzyol, K. S., Hatipoglu, I., Sogut, I., Basalp, A., et al. (2011). Phage displayed HBV core antigen with immunogenic activity. Appl. Biochem. Biotechnol. 165, 1437-1447. doi: 10.1007/s12010-011-9365-1
6. Balcioglu, B. K., Ozdemir-Barahir, A., Hinc, D., Tamerler, C., and Erdag, B. (2014). Cost effective filamentous phage based immunization nanoparticles displaying a full-length hepatitis B virus surface antigen. Adv. Biosci. Biotechnol. 5, 7. doi: 10.4236/abb.2014.51008
7. Bass, S., Greene, R., and Wells, J. A. (1990). Hormone phage: an enrichment method for variant proteins with altered binding properties. Proteins 8, 309-314. doi: 10.1002/prot.340080405
8. Bastien, N., Trudel, M., and Simard, C. (1997). Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus. Virology 234, 118-122. doi: 10.1006/viro.1997.8632
9. Bedi, D., Gillespie, J. W., and Petrenko, V. A. (2014). Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines. Protein Eng. Des. Sel. 27, 235-243. doi: 10.1093/protein/gzu020
10. Bedi, D., Gillespie, J. W., Petrenko, V. A. Jr., Ebner, A., Leitner, M., Hinterdorfer, P., et al. (2013). Targeted delivery of siRNA into breast cancer cells via phage fusion proteins. Mol. Pharm. 10, 551-559. doi: 10.1021/mp3006006
11. Bedi, D., Musacchio, T., Fagbohun, O. A., Gillespie, J. W., Deinnocentes, P., Bird, R. C., et al. (2011). Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes. Nanomedicine 7, 315-323. doi: 10.1016/j.nano.2010.10.004
12. Bille, E., Ure, R., Gray, S. J., Kaczmarski, E. B., Mccarthy, N. D., Nassif, X., et al. (2008). Association of a bacteriophage with meningococcal disease in young adults. PLoS ONE 3:e3885. doi: 10.1371/journal.pone.0003885
13. Bille, E., Zahar, J. R., Perrin, A., Morelle, S., Kriz, P., Jolley, K. A., et al. (2005). A chromosomally integrated bacteriophage in invasive meningococci. J. Exp. Med. 201, 1905-1913. doi: 10.1084/jem.20050112
14. Boratynski, J., Syper, D., Weber-Dabrowska, B., Lusiak-Szelachowska, M., Pozniak, G., and Gorski, A. (2004). Preparation of endotoxin-free bacteriophages. Cell Mol. Biol. Lett. 9, 253-259.
15. Bradbury, A. R., Sidhu, S., Dubel, S., and Mccafferty, J. (2011). Beyond natural antibodies: the power of in vitro display technologies. Nat. Biotechnol. 29, 245-254. doi: 10.1038/nbt.1791
16. Branston, S. D., Wright, J., and Keshavarz-Moore, E. (2015). A non-chromatographic method for the removal of endotoxins from bacteriophages. Biotechnol. Bioeng. 112, 1714-1719. doi: 10.1002/bit.25571
17. Bratkovic, T. (2010). Progress in phage display: evolution of the technique and its application. Cell. Mol. Life Sci. 67, 749-767. doi: 10.1007/s00018-009-0192-2
18. Breitling, F., Dubel, S., Seehaus, T., Klewinghaus, I., and Little, M. (1991). A surface expression vector for antibody screening. Gene 104, 147-153. doi: 10.1016/0378-1119(91)90244-6
19. Canchaya, C., Proux, C., Fournous, G., Bruttin, A., and Brussow, H. (2003). Prophage genomics. Microbiol. Mol. Biol. Rev. 67, 238-276. doi: 10.1128/MMBR.67.2.238-276.2003
20. Cantalupo, P. G., Calgua, B., Zhao, G., Hundesa, A., Wier, A. D., Katz, J. P., et al. (2011). Raw sewage harbors diverse viral populations. MBio 2:e00180-11. doi: 10.1128/mBio.00180-111
21. Carlson, J. C., Badran, A. H., Guggiana-Nilo, D. A., and Liu, D. R. (2014). Negative selection and stringency modulation in phage-assisted continuous evolution. Nat. Chem. Biol. 10, 216-222. doi: 10.1038/nchembio.1453
22. Carrico, Z. M., Farkas, M. E., Zhou, Y., Hsiao, S. C., Marks, J. D., Chokhawala, H., et al. (2012). N-Terminal labeling of filamentous phage to create cancer marker imaging agents. ACS Nano 6, 6675-6680. doi: 10.1021/nn301134z
23. Chai, Y., Li, S., Horikawa, S., Park, M. K., Vodyanoy, V., and Chin, B. A. (2012). Rapid and sensitive detection of Salmonella Typhimurium on eggshells by using wireless biosensors. J. Food. Prot. 75, 631-636. doi: 10.4315/0362-028X.JFP-11-339
24. Chen, I., Choi, Y. A., and Ting, A. Y. (2007). Phage display evolution of a peptide substrate for yeast biotin ligase and application to two-color quantum dot labeling of cell surface proteins. J. Am. Chem. Soc. 129, 6619-6625. doi: 10.1021/ja071013g
25. Chen, P. Y., Dang, X., Klug, M. T., Qi, J., Courchesne, N.-M. D., Burpo, F. J., et al. (2013). Versatile three-dimensional virus-based template for dye-sensitized solar cells with improved electron transport and light harvesting. ACS Nano 7, 6563-6574. doi: 10.1021/nn4014164
26. Chen, P. Y., Hyder, M. N., Mackanic, D., Courchesne, N. M., Qi, J., Klug, M. T., et al. (2014). Assembly of viral hydrogels for three-dimensional conducting nanocomposites. Adv. Mater. 26, 5101-5107. doi: 10.1002/adma.201400828
27. Chen, X., Scala, G., Quinto, I., Liu, W., Chun, T. W., Justement, J. S., et al. (2001). Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes. Nat. Med. 7, 1225-1231. doi: 10.1038/nm1101-1225
28. Chibani-Chennoufi, S., Bruttin, A., Dillmann, M. L., and Brussow, H. (2004). Phage-host interaction: an ecological perspective. J. Bacteriol. 186, 3677-3686. doi: 10.1128/JB.186.12.3677-3686.2004
29. Coull, J. J., Melvin, W. T., Labus, M. B., Raynard, R. S., King, J., and Munro, A. L. (1996). Evaluation of filamentous bacteriophage as immunogens in Atlantic salmon. Biochem. Soc. Trans. 24, 255S.
30. Cuesta, A. M., Suarez, E., Larsen, M., Jensen, K. B., Sanz, L., Compte, M., et al. (2006). Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I. Immunology 117, 502-506. doi: 10.1111/j.1365-2567.2006.02325.x
31. Curtis, S. B., Dunbar, W. S., and Macgillivray, R. T. (2013). Bacteriophage-induced aggregation of oil sands tailings. Biotechnol. Bioeng. 110, 803-811. doi: 10.1002/bit.24745
32. Curtis, S. B., Hewitt, J., Macgillivray, R. T., and Dunbar, W. S. (2009). Biomining with bacteriophage: selectivity of displayed peptides for naturally occurring sphalerite and chalcopyrite. Biotechnol. Bioeng. 102, 644-650. doi: 10.1002/bit.22073
33. Curtis, S. B., Macgillivray, R. T., and Dunbar, W. S. (2011). Effects of bacteriophage on the surface properties of chalcopyrite (CuFeS(2)), and phage-induced flocculation of chalcopyrite, glacial till, and oil sands tailings. Biotechnol. Bioeng. 108, 1579-1590. doi: 10.1002/bit.23097
34. Dahlke Ojennus, D., Mitton-Fry, R. M., and Wuttke, D. S. (1999). Induced alignment and measurement of dipolar couplings of an SH2 domain through direct binding with filamentous phage. J. Biomol. NMR 14, 175-179. doi: 10.1023/A:1008304332574
35. Dalmasso, M., Hill, C., and Ross, R. P. (2014). Exploiting gut bacteriophages for human health. Trends Microbiol. 22, 399-405. doi: 10.1016/j.tim.2014.02.010
36. De Berardinis, P., D'apice, L., Prisco, A., Ombra, M. N., Barba, P., Del Pozzo, G., et al. (1999). Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages. Vaccine 17, 1434-1441. doi: 10.1016/S0264-410X(98)00377-6
37. De Berardinis, P., Sartorius, R., Fanutti, C., Perham, R. N., Del Pozzo, G., and Guardiola, J. (2000). Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses. Nat. Biotechnol. 18, 873-876. doi: 10.1038/78490
38. de la Cruz, V. F., Lal, A. A., and Mccutchan, T. F. (1988). Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage. J. Biol. Chem. 263, 4318-4322.
39. Del Pozzo, G., Mascolo, D., Sartorius, R., Citro, A., Barba, P., D'Apice, L., et al. (2010). Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses. J. Biomed. Biotechnol. 2010:894971. doi: 10.1155/2010/894971
40. Delmastro, P., Meola, A., Monaci, P., Cortese, R., and Galfre, G. (1997). Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration. Vaccine 15, 1276-1285. doi: 10.1016/S0264-410X(97)00072-8
41. Demangel, C., Lafaye, P., and Mazie, J. C. (1996). Reproducing the immune response against the Plasmodium vivax merozoite surface protein 1 with mimotopes selected from a phage-displayed peptide library. Mol. Immunol. 33, 909-916. doi: 10.1016/S0161-5890(96)00058-2
42. Demuth, J., Neve, H., and Witzel, K. P. (1993). Direct electron microscopy study on the morphological diversity of bacteriophage populations in lake Plußsee. Appl. Environ. Microbiol. 59, 3378-3384.
43. Dente, L., Cesareni, G., Micheli, G., Felici, F., Folgori, A., Luzzago, A., et al. (1994). Monoclonal antibodies that recognise filamentous phage: tools for phage display technology. Gene 148, 7-13. doi: 10.1016/0378-1119(94)90227-5
44. Derbise, A., Chenal-Francisque, V., Pouillot, F., Fayolle, C., Prevost, M. C., Medigue, C., et al. (2007). A horizontally acquired filamentous phage contributes to the pathogenicity of the plague bacillus. Mol. Microbiol. 63, 1145-1157. doi: 10.1111/j.1365-2958.2006.05570.x
45. Devlin, J. J., Panganiban, L. C., and Devlin, P. E. (1990). Random peptide libraries: a source of specific protein binding molecules. Science 249, 404-406. doi: 10.1126/science.2143033
46. Dickinson, B. C., Leconte, A. M., Allen, B., Esvelt, K. M., and Liu, D. R. (2013). Experimental interrogation of the path dependence and stochasticity of protein evolution using phage-assisted continuous evolution. Proc. Natl. Acad. Sci. U.S.A. 110, 9007-9012. doi: 10.1073/pnas.1220670110
47. di Marzo Veronese, F., Willis, A. E., Boyer-Thompson, C., Appella, E., and Perham, R. N. (1994). Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage. The V3 loop of HIV-1 gp120. J. Mol. Biol. 243, 167-172. doi: 10.1006/jmbi.1994.1643
48. d'Hérelle, F. (1917). Sur un microbe invisible antagoniste des bacilles dysentérique. Acad. Sci. Paris 165, 3.
49. Eriksson, F., Culp, W. D., Massey, R., Egevad, L., Garland, D., Persson, M. A., et al. (2007). Tumor specific phage particles promote tumor regression in a mouse melanoma model. Cancer Immunol. Immunother. 56, 677-687. doi: 10.1007/s00262-006-0227-226
50. Eriksson, F., Tsagozis, P., Lundberg, K., Parsa, R., Mangsbo, S. M., Persson, M. A., et al. (2009). Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages. J. Immunol. 182, 3105-3111. doi: 10.4049/jimmunol.0800224
51. Esposito, M., Luccarini, I., Cicatiello, V., De Falco, D., Fiorentini, A., Barba, P., et al. (2008). Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes. Mol. Immunol. 45, 1056-1062. doi: 10.1016/j.molimm.2007.07.023
52. Esvelt, K. M., Carlson, J. C., and Liu, D. R. (2011). A system for the continuous directed evolution of biomolecules. Nature 472, 499-503. doi: 10.1038/nature09929
53. Fagbohun, O. A., Bedi, D., Grabchenko, N. I., Deinnocentes, P. A., Bird, R. C., and Petrenko, V. A. (2012). Landscape phages and their fusion proteins targeted to breast cancer cells. Protein Eng. Des. Sel. 25, 271-283. doi: 10.1093/protein/gzs013
54. Fagbohun, O. A., Kazmierczak, R. A., Petrenko, V. A., and Eisenstark, A. (2013). Metastatic prostate cancer cell-specific phage-like particles as a targeted gene-delivery system. J. Nanobiotechnol. 11, 31. doi: 10.1186/1477-3155-11-31
55. Fang, J., Wang, G., Yang, Q., Song, J., Wang, Y., and Wang, L. (2005). The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model. Vaccine 23, 4860-4866. doi: 10.1016/j.vaccine.2005.05.024
56. Fauquet, C. M., Mayo, M. A., Maniloff, J., Desselberger, U., and Ball, L. A. (ed.). (2005). Virus Taxonomy. 8th report of the International Committee on the Taxonomy of Viruses. London: Elsevier/Academic Press.
57. Felici, F., Luzzago, A., Folgori, A., and Cortese, R. (1993). Mimicking of discontinuous epitopes by phage-displayed peptides, II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries. Gene 128, 21-27. doi: 10.1016/0378-1119(93)90148-V
58. Folgori, A., Tafi, R., Meola, A., Felici, F., Galfre, G., Cortese, R., et al. (1994). A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J. 13, 2236-2243.
59. Frenkel, D., Dewachter, I., Van Leuven, F., and Solomon, B. (2003). Reduction of β-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization. Vaccine 21, 1060-1065. doi: 10.1016/S0264-410X(02)00609-6
60. Frenkel, D., Katz, O., and Solomon, B. (2000). Immunization against Alzheimer's β-amyloid plaques via EFRH phage administration. Proc. Natl. Acad. Sci. U.S.A. 97, 11455-11459. doi: 10.1073/pnas.97.21.11455
61. Frenkel, D., and Solomon, B. (2002). Filamentous phage as vector-mediated antibody delivery to the brain. Proc. Natl. Acad. Sci. U.S.A. 99, 5675-5679. doi: 10.1073/pnas.072027199
62. Gao, C., Mao, S., Kaufmann, G., Wirsching, P., Lerner, R. A., and Janda, K. D. (2002). A method for the generation of combinatorial antibody libraries using pIX phage display. Proc. Natl. Acad. Sci. U.S.A. 99, 12612-12616. doi: 10.1073/pnas.192467999
63. Gao, C., Mao, S., Lo, C. H., Wirsching, P., Lerner, R. A., and Janda, K. D. (1999). Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays. Proc. Natl. Acad. Sci. U.S.A. 96, 6025-6030. doi: 10.1073/pnas.96.11.6025
64. Gaubin, M., Fanutti, C., Mishal, Z., Durrbach, A., De Berardinis, P., Sartorius, R., et al. (2003). Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments. DNA Cell Biol. 22, 11-18. doi: 10.1089/104454903321112451
65. Geysen, H. M., Rodda, S. J., and Mason, T. J. (1986). A priori delineation of a peptide which mimics a discontinuous antigenic determinant. Mol. Immunol. 23, 709-715. doi: 10.1016/0161-5890(86)90081-7
66. Ghosh, D., Kohli, A. G., Moser, F., Endy, D., and Belcher, A. M. (2012a). Refactored M13 bacteriophage as a platform for tumor cell imaging and drug delivery. ACS Synth. Biol. 1, 576-582. doi: 10.1021/sb300052u
67. Ghosh, D., Lee, Y., Thomas, S., Kohli, A. G., Yun, D. S., Belcher, A. M., et al. (2012b). M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. Nat. Nanotechnol. 7, 677-682. doi: 10.1038/nnano.2012.146
68. Gonzalez, M. D., Lichtensteiger, C. A., Caughlan, R., and Vimr, E. R. (2002). Conserved filamentous prophage in Escherichia coli O18:K1:H7 and Yersinia pestis biovar orientalis. J. Bacteriol. 184, 6050-6055. doi: 10.1128/JB.184.21.6050-6055.2002
69. Grabowska, A. M., Jennings, R., Laing, P., Darsley, M., Jameson, C. L., Swift, L., et al. (2000). Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2. Virology 269, 47-53. doi: 10.1006/viro.2000.0185
70. Gram, H., Strittmatter, U., Lorenz, M., Gluck, D., and Zenke, G. (1993). Phage display as a rapid gene expression system: production of bioactive cytokine-phage and generation of neutralizing monoclonal antibodies. J. Immunol. Methods 161, 169-176. doi: 10.1016/0022-1759(93)90292-F
71. Greenwood, J., Willis, A. E., and Perham, R. N. (1991). Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens. J. Mol. Biol. 220, 821-827. doi: 10.1016/0022-2836(91)90354-9
72. Hagens, S., and Blasi, U. (2003). Genetically modified filamentous phage as bactericidal agents: a pilot study. Lett. Appl. Microbiol. 37, 318-323. doi: 10.1046/j.1472-765X.2003.01400.x
73. Hagens, S., Habel, A., and Blasi, U. (2006). Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage. Microb. Drug Resist. 12, 164-168. doi: 10.1089/mdr.2006.12.164
74. Hagens, S., Habel, A., Von Ahsen, U., Von Gabain, A., and Blasi, U. (2004). Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage. Antimicrob. Agents Chemother. 48, 3817-3822. doi: 10.1128/AAC.48.10.3817-3822.2004
75. Hall, J. P., Harrison, E., and Brockhurst, M. A. (2013). Viral host-adaptation: insights from evolution experiments with phages. Curr. Opin. Virol. 3, 572-577. doi: 10.1016/j.coviro.2013.07.001
76. Hansen, M. R., Hanson, P., and Pardi, A. (2000). Pf1 filamentous phage as an alignment tool for generating local and global structural information in nucleic acids. J. Biomol. Struct. Dyn. 17(Suppl. 1), 365-369. doi: 10.1080/07391102.2000.10506642
77. Hansen, M. R., Mueller, L., and Pardi, A. (1998). Tunable alignment of macromolecules by filamentous phage yields dipolar coupling interactions. Nat. Struct. Biol. 5, 1065-1074. doi: 10.1038/4176
78. Hashiguchi, S., Yamaguchi, Y., Takeuchi, O., Akira, S., and Sugimura, K. (2010). Immunological basis of M13 phage vaccine: regulation under MyD88 and TLR9 signaling. Biochem. Biophys. Res. Commun. 402, 19-22. doi: 10.1016/j.bbrc.2010.09.094
79. Hassan, F., Kamruzzaman, M., Mekalanos, J. J., and Faruque, S. M. (2010). Satellite phage TLCϕ enables toxigenic conversion by CTX phage through dif site alteration. Nature 467, 982-985. doi: 10.1038/nature09469
80. Henry, K. A., Murira, A., Van Houten, N. E., and Scott, J. K. (2011). Developing strategies to enhance and focus humoral immune responses using filamentous phage as a model antigen. Bioengineered 2, 275-283. doi: 10.4161/bbug.2.5.16559
81. Hess, G. T., Cragnolini, J. J., Popp, M. W., Allen, M. A., Dougan, S. K., Spooner, E., et al. (2012). M13 bacteriophage display framework that allows sortase-mediated modification of surface-accessible phage proteins. Bioconjug. Chem. 23, 1478-1487. doi: 10.1021/bc300130z
82. Hofer, J. S., and Sommaruga, R. (2001). Seasonal dynamics of viruses in an alpine lake: importance of filamentous forms. Aquat. Microb. Ecol. 26, 11. doi: 10.3354/ame026001
83. Hofschneider, P. H., and Mueller-Jensen, K. (1963). On infectious substructures from E. coli bacteriophages. 3. Demonstration and properties of "Ht2" particles. Z. Naturforsch B 18, 922-927.
84. Houimel, M., and Dellagi, K. (2009). Peptide mimotopes of rabies virus glycoprotein with immunogenic activity. Vaccine 27, 4648-4655. doi: 10.1016/j.vaccine.2009.05.055
85. Huang, S., Yang, H., Lakshmanan, R. S., Johnson, M. L., Wan, J., Chen, I. H., et al. (2009). Sequential detection of Salmonella typhimurium and Bacillus anthracis spores using magnetoelastic biosensors. Biosens. Bioelectron. 24, 1730-1736. doi: 10.1016/j.bios.2008.09.006
86. Huang, Y., Chiang, C. Y., Lee, S. K., Gao, Y., Hu, E. L., De Yoreo, J., et al. (2005). Programmable assembly of nanoarchitectures using genetically engineered viruses. Nano Lett. 5, 1429-1434. doi: 10.1021/nl050795d
87. Hufton, S. E., Moerkerk, P. T., Meulemans, E. V., De Bruine, A., Arends, J. W., and Hoogenboom, H. R. (1999). Phage display of cDNA repertoires: the pVI display system and its applications for the selection of immunogenic ligands. J. Immunol. Methods 231, 39-51. doi: 10.1016/S0022-1759(99)00139-8
88. Husimi, Y. (1989). Selection and evolution of bacteriophages in cellstat. Adv. Biophys. 25, 1-43. doi: 10.1016/0065-227X(89)90003-8
89. Iida, T., Hattori, A., Tagomori, K., Nasu, H., Naim, R., and Honda, T. (2001). Filamentous phage associated with recent pandemic strains of Vibrio parahaemolyticus. Emerg. Infect. Dis. 7, 477-478. doi: 10.3201/eid0703.010325
90. Irving, M. B., Craig, L., Menendez, A., Gangadhar, B. P., Montero, M., van Houten, N. E., et al. (2010). Exploring peptide mimics for the production of antibodies against discontinuous protein epitopes. Mol. Immunol. 47, 1137-1148. doi: 10.1016/j.molimm.2009.10.015
91. Jayanna, P. K., Bedi, D., Deinnocentes, P., Bird, R. C., and Petrenko, V. A. (2010a). Landscape phage ligands for PC3 prostate carcinoma cells. Protein Eng. Des. Sel. 23, 423-430. doi: 10.1093/protein/gzq011
92. Jayanna, P. K., Bedi, D., Gillespie, J. W., Deinnocentes, P., Wang, T., Torchilin, V. P., et al. (2010b). Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency. Nanomedicine 6, 538-546. doi: 10.1016/j.nano.2010.01.005
93. Jian, H., Xu, J., Xiao, X., and Wang, F. (2012). Dynamic modulation of DNA replication and gene transcription in deep-sea filamentous phage SW1 in response to changes of host growth and temperature. PLoS ONE 7:e41578. doi: 10.1371/journal.pone.0041578
94. Kajihara, Y., Hashiguchi, S., Ito, Y., and Sugimura, K. (2000). Th2-type immune response induced by a phage clone displaying a CTLA4-binding domain mimic-motif. Gene Ther. Mol. Biol. 5, 6.
95. Kamiunten, H., and Wakimoto, S. (1982). Effect of infection with filamentous phage xf on the growth, ultrastructure and virulence of Xanthomonas campestris pv. oryzae N 5850. Jpn. J. Phytopatholo. 48, 642-647. doi: 10.3186/jjphytopath.48.642
96. Kang, A. S., Barbas, C. F., Janda, K. D., Benkovic, S. J., and Lerner, R. A. (1991). Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc. Natl. Acad. Sci. U.S.A. 88, 4363-4366. doi: 10.1073/pnas.88.10.4363
97. Kawecki, T. J., Lenski, R. E., Ebert, D., Hollis, B., Olivieri, I., and Whitlock, M. C. (2012). Experimental evolution. Trends Ecol. Evol. 27, 547-560. doi: 10.1016/j.tree.2012.06.001
98. Kehoe, J. W., and Kay, B. K. (2005). Filamentous phage display in the new millennium. Chem. Rev. 105, 4056-4072. doi: 10.1021/cr000261r
99. Khatoon, H., Iyer, R. V., and Iyer, V. N. (1972). A new filamentous bacteriophage with sex-factor specificity. Virology 48, 145-155. doi: 10.1016/0042-6822(72)90122-5
100. Kim, M. S., Park, E. J., Roh, S. W., and Bae, J. W. (2011). Diversity and abundance of single-stranded DNA viruses in human feces. Appl. Environ. Microbiol. 77, 8062-8070. doi: 10.1128/AEM.06331-1
101. Kim, Y. J., Jin, Y. H., Salieb-Beugelaar, G. B., Nam, C. H., and Stieglitz, T. (2014). Genetically engineered bacteriophage delivers a tumor necrosis factor alpha antagonist coating on neural electrodes. Biomed. Mater. 9:015009. doi: 10.1088/1748-6041/9/1/015009
102. Kim, Y. J., Lebreton, F., Kaiser, C., Cruciere, C., and Remond, M. (2004). Expression of a foot-and-mouth disease virus immunodominant epitope by a filamentous bacteriophage vector. Arch. Virol. 149, 365-377. doi: 10.1007/s00705-003-0192-198
103. Kishchenko, G., Batliwala, H., and Makowski, L. (1994). Structure of a foreign peptide displayed on the surface of bacteriophage M13. J. Mol. Biol. 241, 208-213. doi: 10.1006/jmbi.1994.1489
104. Kneissel, S., Queitsch, I., Petersen, G., Behrsing, O., Micheel, B., and Dubel, S. (1999). Epitope structures recognised by antibodies against the major coat protein (g8p) of filamentous bacteriophage fd (Inoviridae). J. Mol. Biol. 288, 21-28. doi: 10.1006/jmbi.1999.2676
105. Knittelfelder, R., Riemer, A. B., and Jensen-Jarolim, E. (2009). Mimotope vaccination-from allergy to cancer. Expert. Opin. Biol. Ther. 9, 493-506. doi: 10.1517/14712590902870386
106. Koide, A., and Koide, S. (2012). Affinity maturation of single-domain antibodies by yeast surface display. Methods Mol. Biol. 911, 431-443. doi: 10.1007/978-1-61779-968-6-26
107. Kölsch, E., Diller, E., Weber, G., and Davies, A. J. (1971). Genetics of the immune response. I. The immune response to the phage fd in high and low responding inbred strains of mice. Eur. J. Immunol. 1, 201-210. doi: 10.1002/eji.1830010310
108. Ksendzovsky, A., Walbridge, S., Saunders, R. C., Asthagiri, A. R., Heiss, J. D., and Lonser, R. R. (2012). Convection-enhanced delivery of M13 bacteriophage to the brain. J. Neurosurg. 117, 197-203. doi: 10.3171/2012.4.JNS111528
109. Kwasnikowski, P., Kristensen, P., and Markiewicz, W. T. (2005). Multivalent display system on filamentous bacteriophage pVII minor coat protein. J. Immunol. Methods 307, 135-143. doi: 10.1016/j.jim.2005.10.002
110. Lakshmanan, R. S., Guntupalli, R., Hu, J., Kim, D. J., Petrenko, V. A., Barbaree, J. M., et al. (2007). Phage immobilized magnetoelastic sensor for the detection of Salmonella typhimurium. J. Microbiol. Methods 71, 55-60. doi: 10.1016/j.mimet.2007.07.012
111. Lang, Q., Wang, F., Yin, L., Liu, M., Petrenko, V. A., and Liu, A. (2014). Specific probe selection from landscape phage display library and its application in enzyme-linked immunosorbent assay of free prostate-specific antigen. Anal. Chem. 86, 2767-2774. doi: 10.1021/ac404189k
112. Lavie, V., Becker, M., Cohen-Kupiec, R., Yacoby, I., Koppel, R., Wedenig, M., et al. (2004). EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials. J. Mol. Neurosci. 24, 105-113. doi: 10.1385/JMN:24:1105
113. Lee, S. W., Mao, C., Flynn, C. E., and Belcher, A. M. (2002). Ordering of quantum dots using genetically engineered viruses. Science 296, 892-895. doi: 10.1126/science.1068054
114. Lee, Y. J., Yi, H., Kim, W. J., Kang, K., Yun, D. S., Strano, M. S., et al. (2009). Fabricating genetically engineered high-power lithium-ion batteries using multiple virus genes. Science 324, 1051-1055. doi: 10.1126/science.1171541
115. Li, K., Chen, Y., Li, S., Nguyen, H. G., Niu, Z., You, S., et al. (2010a). Chemical modification of M13 bacteriophage and its application in cancer cell imaging. Bioconjug. Chem. 21, 1369-1377. doi: 10.1021/bc900405q
116. Li, S., Li, Y., Chen, H., Horikawa, S., Shen, W., Simonian, A., et al. (2010b). Direct detection of Salmonella typhimurium on fresh produce using phage-based magnetoelastic biosensors. Biosens. Bioelectron. 26, 1313-1319. doi: 10.1016/j.bios.2010.07.029
117. Li, Y., Ning, Y., Wang, Y., Peng, D., Jiang, Y., Zhang, L., et al. (2010c). Mimotopes selected with a neutralizing antibody against urease B from Helicobacter pylori induce enzyme inhibitory antibodies in mice upon vaccination. BMC Biotechnol. 10:84. doi: 10.1186/1472-6750-10-84
118. Lidqvist, M., Nilsson, O., Holmgren, J., Hall, C., and Fermer, C. (2008). Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies. J. Immunol. Methods 337, 88-96. doi: 10.1016/j.jim.2008.06.002
119. Lin, A., Jimenez, J., Derr, J., Vera, P., Manapat, M. L., Esvelt, K. M., et al. (2011). Inhibition of bacterial conjugation by phage M13 and its protein g3p: quantitative analysis and model. PLoS ONE 6:e19991. doi: 10.1371/journal.pone.0019991
120. Lippow, S. M., Wittrup, K. D., and Tidor, B. (2007). Computational design of antibody-affinity improvement beyond in vivo maturation. Nat. Biotechnol. 25, 1171-1176. doi: 10.1038/nbt1336
121. Loeb, T. (1960). Isolation of a bacteriophage specific for the F plus and Hfr mating types of Escherichia coli K-12. Science 131, 932-933. doi: 10.1126/science.131.3404.932
122. Lu, T. K., and Collins, J. J. (2009). Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc. Natl. Acad. Sci. U.S.A. 106, 4629-4634. doi: 10.1073/pnas.0800442106
123. Malik, P., Terry, T. D., Gowda, L. R., Langara, A., Petukhov, S. A., Symmons, M. F., et al. (1996). Role of capsid structure and membrane protein processing in determining the size and copy number of peptides displayed on the major coat protein of filamentous bacteriophage. J. Mol. Biol. 260, 9-21. doi: 10.1006/jmbi.1996.0378
124. Manoutcharian, K., Diaz-Orea, A., Gevorkian, G., Fragoso, G., Acero, G., Gonzalez, E., et al. (2004). Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. Vet. Immunol. Immunopathol. 99, 11-24. doi: 10.1016/j.vetimm.2003.12.009
125. Mao, C., Flynn, C. E., Hayhurst, A., Sweeney, R., Qi, J., Georgiou, G., et al. (2003). Viral assembly of oriented quantum dot nanowires. Proc. Natl. Acad. Sci. U.S.A. 100, 6946-6951. doi: 10.1073/pnas.0832310100
126. Mao, C., Solis, D. J., Reiss, B. D., Kottmann, S. T., Sweeney, R. Y., Hayhurst, A., et al. (2004). Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires. Science 303, 213-217. doi: 10.1126/science.1092740
127. Mao, J. Y., Belcher, A. M., and Van Vliet, K. J. (2010). Genetically engineered phage fibers and coatings for antibacterial applications. Adv. Funct. Mater. 20, 5. doi: 10.1002/adfm.200900782
128. Marks, J. D., Hoogenboom, H. R., Griffiths, A. D., and Winter, G. (1992). Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system. J. Biol. Chem. 267, 16007-16010.
129. Marvin, D. A. (1990). Model-building studies of Inovirus: genetic variations on a geometric theme. Int. J. Biol. Macromol. 12, 125-138. doi: 10.1016/0141-8130(90)90064-H
130. Marvin, D. A. (1998). Filamentous phage structure, infection and assembly. Curr. Opin. Struct. Biol. 8, 150-158. doi: 10.1016/S0959-440X(98)80032-8
131. Marvin, D. A., and Hoffmann-Berling, H. (1963). A fibrous DNA phage (Fd) and a spherical RNA phage (Fr) specific for male strains of E. coli. II. Physical characteristics. Z. Naturforsch. B 18, 884-893. doi: 10.1515/znb-1963-1106
132. Mascolo, D., Barba, P., De Berardinis, P., Di Rosa, F., and Del Pozzo, G. (2007). Phage display of a CTL epitope elicits a long-term in vivo cytotoxic response. FEMS Immunol. Med. Microbiol. 50, 59-66. doi: 10.1111/j.1574-695X.2007.00229.x
133. May, T., Tsuruta, K., and Okabe, S. (2011). Exposure of conjugative plasmid carrying Escherichia coli biofilms to male-specific bacteriophages. ISME J. 5, 771-775. doi: 10.1038/ismej.2010.158
134. McCafferty, J., Griffiths, A. D., Winter, G., and Chiswell, D. J. (1990). Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348, 552-554. doi: 10.1038/348552a0
135. McConnell, S. J., Kendall, M. L., Reilly, T. M., and Hoess, R. H. (1994). Constrained peptide libraries as a tool for finding mimotopes. Gene 151, 115-118. doi: 10.1016/0378-1119(94)90640-8
136. Melzer, H., Baier, K., Felici, F., Von Specht, B. U., Wiedermann, G., Kollaritsch, H., et al. (2003). Humoral immune response against proteophosphoglycan surface antigens of Entamoeba histolytica elicited by immunization with synthetic mimotope peptides. FEMS Immunol. Med. Microbiol. 37, 179-183. doi: 10.1016/S092882440300074-9
137. Melzer, H., Fortugno, P., Mansouri, E., Felici, F., Marinets, A., Wiedermann, G., et al. (2002). Antigenicity and immunogenicity of phage library-selected peptide mimics of the major surface proteophosphoglycan antigens of Entamoeba histolytica. Parasite Immunol. 24, 321-328. doi: 10.1046/j.1365-3024.2002.00463.x
138. Menendez, T., De Haz, I., Delgado, M., Garay, H., Martin, A., and Vispo, N. S. (2001). Immunisation with phage-displayed variable region 2 from meningococcal PorA outer membrane protein induces bactericidal antibodies against Neisseria meningitidis. Immunol. Lett. 78, 143-148. doi: 10.1016/S0165-2478(01)00245-0
139. Meola, A., Delmastro, P., Monaci, P., Luzzago, A., Nicosia, A., Felici, F., et al. (1995). Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. J. Immunol. 154, 3162-3172.
140. Meyer, A. J., and Ellington, A. D. (2011). Molecular evolution picks up the PACE. Nat. Biotechnol. 29, 502-503. doi: 10.1038/nbt.1884
141. Meynell, G. G., and Lawn, A. M. (1968). Filamentous phages specific for the I sex factor. Nature 217, 1184-1186. doi: 10.1038/2171184a0
142. Minenkova, O. O., Ilyichev, A. A., Kishchenko, G. P., and Petrenko, V. A. (1993). Design of specific immunogens using filamentous phage as the carrier. Gene 128, 85-88. doi: 10.1016/0378-1119(93)90157-X
143. Molenaar, T. J., Michon, I., De Haas, S. A., Van Berkel, T. J., Kuiper, J., and Biessen, E. A. (2002). Uptake and processing of modified bacteriophage M13 in mice: implications for phage display. Virology 293, 182-191. doi: 10.1006/viro.2001.1254
144. Moradpour, Z., Sepehrizadeh, Z., Rahbarizadeh, F., Ghasemian, A., Yazdi, M. T., and Shahverdi, A. R. (2009). Genetically engineered phage harbouring the lethal catabolite gene activator protein gene with an inducer-independent promoter for biocontrol of Escherichia coli. FEMS Microbiol. Lett. 296, 67-71. doi: 10.1111/j.1574-6968.2009.01620.x
145. Morales, J., Martinez, J. J., Manoutcharian, K., Hernandez, M., Fleury, A., Gevorkian, G., et al. (2008). Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. Vaccine 26, 2899-2905. doi: 10.1016/j.vaccine.2008.03.042
146. Motti, C., Nuzzo, M., Meola, A., Galfre, G., Felici, F., Cortese, R., et al. (1994). Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library. Gene 146, 191-198. doi: 10.1016/0378-1119(94)90292-5
147. Murira, A. (2014). Characterization of Molecular Correlates of the Chronic Humoral Immune Response: Clues towards Eliciting Broadly Neutralizing Antibodies against HIV. Ph.D. thesis, Simon Fraser University, Burnaby, BC.
148. Murugaiyan, S., Bae, J. Y., Wu, J., Lee, S. D., Um, H. Y., Choi, H. K., et al. (2011). Characterization of filamentous bacteriophage PE226 infecting Ralstonia solanacearum strains. J. Appl. Microbiol. 110, 296-303. doi: 10.1111/j.1365-2672.2010.04882.x
149. Murugesan, M., Abbineni, G., Nimmo, S. L., Cao, B., and Mao, C. (2013). Virus-based photo-responsive nanowires formed by linking site-directed mutagenesis and chemical reaction. Sci. Rep. 3:1820. doi: 10.1038/srep01820
150. Nam, K. T., Kim, D. W., Yoo, P. J., Chiang, C. Y., Meethong, N., Hammond, P. T., et al. (2006). Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes. Science 312, 885-888. doi: 10.1126/science.1122716
151. Nam, K. T., Wartena, R., Yoo, P. J., Liau, F. W., Lee, Y. J., Chiang, Y. M., et al. (2008). Stamped microbattery electrodes based on self-assembled M13 viruses. Proc. Natl. Acad. Sci. U.S.A. 105, 17227-17231. doi: 10.1073/pnas.0711620105
152. Nam, Y. S., Magyar, A. P., Lee, D., Kim, J. W., Yun, D. S., Park, H., et al. (2010a). Biologically templated photocatalytic nanostructures for sustained light-driven water oxidation. Nat. Nanotechnol. 5, 340-344. doi: 10.1038/nnano.2010.57
153. Nam, Y. S., Shin, T., Park, H., Magyar, A. P., Choi, K., Fantner, G., et al. (2010b). Virus-templated assembly of porphyrins into light-harvesting nanoantennae. J. Am. Chem. Soc. 132, 1462-1463. doi: 10.1021/ja908812b
154. Nanduri, V., Bhunia, A. K., Tu, S. I., Paoli, G. C., and Brewster, J. D. (2007). SPR biosensor for the detection of L. monocytogenes using phage-displayed antibody. Biosens. Bioelectron. 23, 248-252. doi: 10.1016/j.bios.2007.04.007
155. Neltner, B., Peddie, B., Xu, A., Doenlen, W., Durand, K., Yun, D. S., et al. (2010). Production of hydrogen using nanocrystalline protein-templated catalysts on m13 phage. ACS Nano 4, 3227-3235. doi: 10.1021/nn100346h
156. Ng, S., Jafari, M. R., Matochko, W. L., and Derda, R. (2012). Quantitative synthesis of genetically encoded glycopeptide libraries displayed on M13 phage. ACS Chem. Biol. 7, 1482-1487. doi: 10.1021/cb300187t
157. Oh, D., Dang, X., Yi, H., Allen, M. A., Xu, K., Lee, Y. J., et al. (2012). Graphene sheets stabilized on genetically engineered M13 viral templates as conducting frameworks for hybrid energy-storage materials. Small 8, 1006-1011. doi: 10.1002/smll.201102036
158. Olsen, E. V., Sorokulova, I. B., Petrenko, V. A., Chen, I. H., Barbaree, J. M., and Vodyanoy, V. J. (2006). Affinity-selected filamentous bacteriophage as a probe for acoustic wave biodetectors of Salmonella typhimurium. Biosens. Bioelectron. 21, 1434-1442. doi: 10.1016/j.bios.2005.06.004
159. Pacheco-Gomez, R., Kraemer, J., Stokoe, S., England, H. J., Penn, C. W., Stanley, E., et al. (2012). Detection of pathogenic bacteria using a homogeneous immunoassay based on shear alignment of virus particles and linear dichroism. Anal. Chem. 84, 91-97. doi: 10.1021/ac201544h
160. Pande, J., Szewczyk, M. M., and Grover, A. K. (2010). Phage display: concept, innovations, applications and future. Biotechnol. Adv. 28, 849-858. doi: 10.1016/j.biotechadv.2010.07.004
161. Parmley, S. F., and Smith, G. P. (1988). Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 73, 305-318. doi: 10.1016/0378-1119(88)90495-7
162. Petrenko, V. A., and Makowski, L. (1993). "Potential applications of phage display to bioremediation," in Bioremediation of Chlorinated and Polycyclic Aromatic Hydrocarbon Compounds, eds R. E. Hinchee, L. Semprini, and S. K. Ong (Columbus, OH: Taylor and Francis Group), 266-280.
163. Petrenko, V. A., Smith, G. P., Gong, X., and Quinn, T. (1996). A library of organic landscapes on filamentous phage. Protein Eng. 9, 797-801. doi: 10.1093/protein/9.9.797
164. Pina, S., Creus, A., Gonzaalez, N., Gironees, R., Felip, M., and Sommaruga, R. (1998). Abundance, morphology and distribution of planktonic virus-like particles in two high-mountain lakes. J. Plankton Res. 20:8. doi: 10.1093/plankt/20.12.2413
165. Plotkin, S. A. (2010). Correlates of protection induced by vaccination. Clin. Vacc. Immunol. 17, 1055-1065. doi: 10.1128/CVI.00131-110
166. Poul, M. A., and Marks, J. D. (1999). Targeted gene delivery to mammalian cells by filamentous bacteriophage. J. Mol. Biol. 288, 203-211. doi: 10.1006/jmbi.1999.2678
167. Pratt, D., Tzagoloff, H., and Beaudoin, J. (1969). Conditional lethal mutants of the small filamentous coliphage M13. II. Two genes for coat proteins. Virology 39, 42-53. doi: 10.1016/0042-6822(69)90346-8
168. Prezzi, C., Nuzzo, M., Meola, A., Delmastro, P., Galfre, G., Cortese, R., et al. (1996). Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J. Immunol. 156, 4504-4513.
169. Puntoriero, G., Meola, A., Lahm, A., Zucchelli, S., Ercole, B. B., Tafi, R., et al. (1998). Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO J. 17, 3521-3533. doi: 10.1093/emboj/17.13.3521
170. Rakonjac, J. (2012). "Filamentous bacteriophages: biology and applications," in eLS (the Encyclopaedia of Life Sciences), Chichester: John Wiley & Sons, Ltd. doi: 10.1002/9780470015902.a0000777
171. Rakonjac, J., Bennett, N. J., Spagnuolo, J., Gagic, D., and Russel, M. (2011). Filamentous bacteriophage: biology, phage display and nanotechnology applications. Curr. Issues Mol. Biol. 13, 51-76.
172. Rakover, I. S., Zabavnik, N., Kopel, R., Paz-Rozner, M., and Solomon, B. (2010). Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope. J. Neuroimmunol. 225, 68-76. doi: 10.1016/j.jneuroim.2010.04.014
173. Rao, K. V., He, Y. X., and Kalyanasundaram, R. (2003). Expression of a 28-kilodalton glutathione S-transferase antigen of Schistosoma mansoni on the surface of filamentous phages and evaluation of its vaccine potential. Clin. Diagn. Lab. Immunol. 10, 536-541. doi: 10.1128/cdli.10.4.536-541.2003
174. Raymond-Bouchard, I., Carroll, C. S., Nesbitt, J. R., Henry, K. A., Pinto, L. J., Moinzadeh, M., et al. (2012). Structural requirements for the activity of the MirB ferrisiderophore transporter of Aspergillus fumigatus. Eukaryot. Cell 11, 1333-1344. doi: 10.1128/EC.00159-112
175. Roehnisch, T., Then, C., Nagel, W., Blumenthal, C., Braciak, T., Donzeau, M., et al. (2013). Chemically linked phage idiotype vaccination in the murine B cell lymphoma 1 model. J. Transl. Med. 11:267. doi: 10.1186/1479-5876-11-267
176. Roehnisch, T., Then, C., Nagel, W., Blumenthal, C., Braciak, T., Donzeau, M., et al. (2014). Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma. J. Transl. Med. 12, 119. doi: 10.1186/1479-5876-12-119
177. Romanov, V. I., Durand, D. B., and Petrenko, V. A. (2001). Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Prostate 47, 239-251. doi: 10.1002/pros.1068
178. Rondot, S., Koch, J., Breitling, F., and Dubel, S. (2001). A helper phage to improve single-chain antibody presentation in phage display. Nat. Biotechnol. 19, 75-78. doi: 10.1038/83567
179. Rosario, K., Nilsson, C., Lim, Y. W., Ruan, Y., and Breitbart, M. (2009). Metagenomic analysis of viruses in reclaimed water. Environ. Microbiol. 11, 2806-2820. doi: 10.1111/j.1462-2920.2009.01964.x
180. Roux, S., Enault, F., Robin, A., Ravet, V., Personnic, S., Theil, S., et al. (2012). Assessing the diversity and specificity of two freshwater viral communities through metagenomics. PLoS ONE 7:e33641. doi: 10.1371/journal.pone.0033641
181. Rubinchik, E., and Chow, A. W. (2000). Recombinant expression and neutralizing activity of an MHC class II binding epitope of toxic shock syndrome toxin-1. Vaccine 18, 2312-2320. doi: 10.1016/S0264-410X(99)00554-X
182. Rudolf, M. P., Vogel, M., Kricek, F., Ruf, C., Zurcher, A. W., Reuschel, R., et al. (1998). Epitope-specific antibody response to IgE by mimotope immunization. J. Immunol. 160, 3315-3321.
183. Salivar, W. O., Tzagoloff, H., and Pratt, D. (1964). Some physical-chemical and biological properties of the rod-shaped coliphage M13. Virology 24, 359-371. doi: 10.1016/0042-6822(64)90173-4
184. Samoylov, A., Cox, N., Cochran, A., Wolfe, K., Donovan, C., Kutzler, M., et al. (2012). Generation and characterization of phage-GnRH chemical conjugates for potential use in cat and dog immunocontraception. Reprod. Domest. Anim. 47(Suppl. 6), 406-411. doi: 10.1111/rda.12061
185. Samoylova, T. I., Cochran, A. M., Samoylov, A. M., Schemera, B., Breiteneicher, A. H., Ditchkoff, S. S., et al. (2012a). Phage display allows identification of zona pellucida-binding peptides with species-specific properties: novel approach for development of contraceptive vaccines for wildlife. J. Biotechnol. 162, 311-318. doi: 10.1016/j.jbiotec.2012.10.006
186. Samoylova, T. I., Norris, M. D., Samoylov, A. M., Cochran, A. M., Wolfe, K. G., Petrenko, V. A., et al. (2012b). Infective and inactivated filamentous phage as carriers for immunogenic peptides. J. Virol. Methods 183, 63-68. doi: 10.1016/j.jviromet.2012.03.032
187. Sartorius, R., Bettua, C., D'apice, L., Caivano, A., Trovato, M., Russo, D., et al. (2011). Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants. Eur. J. Immunol. 41, 2573-2584. doi: 10.1002/eji.201141526
188. Sartorius, R., Pisu, P., D'apice, L., Pizzella, L., Romano, C., Cortese, G., et al. (2008). The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses. J. Immunol. 180, 3719-3728. doi: 10.4049/jimmunol.180.6.3719
189. Scala, G., Chen, X., Liu, W., Telles, J. N., Cohen, O. J., Vaccarezza, M., et al. (1999). Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera. J. Immunol. 162, 6155-6161.
190. Schmelcher, M., and Loessner, M. J. (2014). Application of bacteriophages for detection of foodborne pathogens. Bacteriophage 4:e28137. doi: 10.4161/bact.28137
191. Scott, J. K., and Smith, G. P. (1990). Searching for peptide ligands with an epitope library. Science 249, 386-390. doi: 10.1126/science.1696028
192. Shi, L., Wheeler, J. C., Sweet, R. W., Lu, J., Luo, J., Tornetta, M., et al. (2010). De novo selection of high-affinity antibodies from synthetic Fab libraries displayed on phage as pIX fusion proteins. J. Mol. Biol. 397, 385-396. doi: 10.1016/j.jmb.2010.01.034
193. Sidhu, S. S., Weiss, G. A., and Wells, J. A. (2000). High copy display of large proteins on phage for functional selections. J. Mol. Biol. 296, 487-495. doi: 10.1006/jmbi.1999.3465
194. Smith, G. P. (1985). Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315-1317. doi: 10.1126/science.4001944
195. Smith, G. P., and Fernandez, A. M. (2004). Effect of DNA copy number on genetic stability of phage-displayed peptides. Biotechniques 36, 610-614.
196. Smith, G. P., and Gingrich, T. R. (2005). Hydroxyapatite chromatography of phage-display virions. BioTechniques 39, 879-884. doi: 10.2144/000112032
197. Smith, G. P., and Petrenko, V. A. (1997). Phage display. Chem. Rev. 97, 391-410. doi: 10.1021/cr960065d
198. Smith, G. P., and Scott, J. K. (1993). Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217, 228-257. doi: 10.1016/0076-6879(93)17065-D
199. Solomon, B. (2005). Generation of anti-β-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination. Vaccine 23, 2327-2330. doi: 10.1016/j.vaccine.2005.01.034
200. Solomon, B. (2008). Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatment. J. Alzheimers Dis. 15, 193-198.
201. Su, Q. P., Wen, D. Z., Yang, Q., Zhang, Y. H., Liu, C., and Wang, L. (2007). Comparison of phage pVIII and KLH as vector in inducing the production of cytokines in C57BL/6J mice. Vaccine 25, 970-975. doi: 10.1016/j.vaccine.2006.08.045
202. Sulakvelidze, A., Alavidze, Z., and Morris, J. G. Jr. (2001). Bacteriophage therapy. Antimicrob. Agents Chemother. 45, 649-659. doi: 10.1128/AAC.45.3.649-659.2001
203. Suttle, C. A. (2005). Viruses in the sea. Nature 437, 356-361. doi: 10.1038/nature04160
204. Tanaka, K., Nishimura, M., Yamaguchi, Y., Hashiguchi, S., Takiguchi, S., Yamaguchi, M., et al. (2011). A mimotope peptide of Aβ42 fibril-specific antibodies with Aβ42 fibrillation inhibitory activity induces anti-Aβ42 conformer antibody response by a displayed form on an M13 phage in mice. J. Neuroimmunol. 236, 27-38. doi: 10.1016/j.jneuroim.2011.04.010
205. Terry, T. D., Malik, P., and Perham, R. N. (1997). Accessibility of peptides displayed on filamentous bacteriophage virions: susceptibility to proteinases. Biol. Chem. 378, 523-530. doi: 10.1515/bchm.1997.378.6.523
206. Tornetta, M., Baker, S., Whitaker, B., Lu, J., Chen, Q., Pisors, E., et al. (2010). Antibody Fab display and selection through fusion to the pIX coat protein of filamentous phage. J. Immunol. Methods 360, 39-46. doi: 10.1016/j.jim.2010.06.001
207. Twort, F. W. (1915). An investigation on the nature of ultra-microscopic viruses. Lancet 186:3. doi: 10.1016/S0140-6736(01)20383-3
208. Ulivieri, C., Citro, A., Ivaldi, F., Mascolo, D., Ghittoni, R., Fanigliulo, D., et al. (2008). Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides. Immunol. Lett. 119, 62-70. doi: 10.1016/j.imlet.2008.04.004
209. Vaks, L., and Benhar, I. (2011). In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines. J. Nanobiotechnol. 9, 58. doi: 10.1186/1477-3155-9-58
210. Van Gerven, N., De Greve, H., and Hernalsteens, J. P. (2008). Presentation of the functional receptor-binding domain of the bacterial adhesin F17a-G on bacteriophage M13. Antonie Van Leeuwenhoek 93, 219-226. doi: 10.1007/s10482-007-9195-x
211. van Houten, N. E., Henry, K. A., Smith, G. P., and Scott, J. K. (2010). Engineering filamentous phage carriers to improve focusing of antibody responses against peptides. Vaccine 28, 2174-2185. doi: 10.1016/j.vaccine.2009.12.059
212. van Houten, N. E., Zwick, M. B., Menendez, A., and Scott, J. K. (2006). Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide. Vaccine 24, 4188-4200. doi: 10.1016/j.vaccine.2006.01.001
213. Van Regenmortel, M. H. (2012). Basic research in HIV vaccinology is hampered by reductionist thinking. Front. Immunol. 3:194. doi: 10.3389/fimmu.2012.00194
214. Waldor, M. K., and Mekalanos, J. J. (1996). Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272, 1910-1914. doi: 10.1126/science.272.5270.1910
215. Wan, Y., Wu, Y., Bian, J., Wang, X. Z., Zhou, W., Jia, Z. C., et al. (2001). Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine. Vaccine 19, 2918-2923. doi: 10.1016/S0264-410X(00)00561-2
216. Wan, Y., Wu, Y., Zhou, J., Zou, L., Liang, Y., Zhao, J., et al. (2005). Cross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments. Eur. J. Immunol. 35, 2041-2050. doi: 10.1002/eji.200425322
217. Wang, F., Liu, P., Sun, L., Li, C., Petrenko, V. A., and Liu, A. (2014a). Bio-mimetic nanostructure self-assembled from Au@Ag heterogeneous nanorods and phage fusion proteins for targeted tumor optical detection and photothermal therapy. Sci. Rep. 4:6808. doi: 10.1038/srep06808
218. Wang, T., Hartner, W. C., Gillespie, J. W., Praveen, K. P., Yang, S., Mei, L. A., et al. (2014b). Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein. Nanomedicine 10, 421-430. doi: 10.1016/j.nano.2013.08.009
219. Wang, T., Yang, S., Mei, L. A., Parmar, C. K., Gillespie, J. W., Praveen, K. P., et al. (2014c). Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumors. Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-14-0052
220. Wang, Y., Su, Q., Dong, S., Shi, H., Gao, X., and Wang, L. (2014d). Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice. Hum. Vaccin. Immunother. 10, 1057-1063. doi: 10.4161/hv.27714
221. Wang, G., Sun, M., Fang, J., Yang, Q., Tong, H., and Wang, L. (2006). Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice. Vaccine 24, 6065-6073. doi: 10.1016/j.vaccine.2006.05.022
222. Wang, T., D'souza, G. G., Bedi, D., Fagbohun, O. A., Potturi, L. P., Papahadjopoulos-Sternberg, B., et al. (2010a). Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein. Nanomedicine 5, 563-574. doi: 10.2217/nnm.10.30
223. Wang, T., Petrenko, V. A., and Torchilin, V. P. (2010b). Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity. Mol. Pharm. 7, 1007-1014. doi: 10.1021/mp1001125
224. Wang, T., Yang, S., Petrenko, V. A., and Torchilin, V. P. (2010c). Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein. Mol. Pharm. 7, 1149-1158. doi: 10.1021/mp1000229
225. Webb, J. S., Lau, M., and Kjelleberg, S. (2004). Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development. J. Bacteriol. 186, 8066-8073. doi: 10.1128/JB.186.23.8066-8073.2004
226. Welsh, L. C., Symmons, M. F., Nave, C., Perham, R. N., Marseglia, E. A., and Marvin, D. A. (1996). Evidence for tilted smectic liquid crystalline packing of fd inovirus from X-ray fiber diffraction. Macromolecules 29, 8. doi: 10.1021/ma9605614
227. Wichman, H. A., and Brown, C. J. (2010). Experimental evolution of viruses: Microviridae as a model system. Philos. Trans. R. Soc. Lond. B Biol. Sci. 365, 2495-2501. doi: 10.1098/rstb.2010.0053
228. Willis, A. E., Perham, R. N., and Wraith, D. (1993). Immunological properties of foreign peptides in multiple display on a filamentous bacteriophage. Gene 128, 79-83. doi: 10.1016/0378-1119(93)90156-W
229. Woolford, J. L. Jr., Steinman, H. M., and Webster, R. E. (1977). Adsorption protein of bacteriophage fl: solubilization in deoxycholate and localization in the fl virion. Biochemistry 16, 2694-2700. doi: 10.1021/bi00631a017
230. Wu, L., Huang, T., Yang, L., Pan, J., Zhu, S., and Yan, X. (2011). Sensitive and selective bacterial detection using tetracysteine-tagged phages in conjunction with biarsenical dye. Angew. Chem. Int. Ed. Engl. 50, 5873-5877. doi: 10.1002/anie.201100334
231. Wu, Y., Wan, Y., Bian, J., Zhao, J., Jia, Z., Zhou, L., et al. (2002). Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine p815 model. Int. J. Cancer 98, 748-753. doi: 10.1002/ijc.10260
232. Xia, Y. J., Wen, W. H., Huang, W. Q., and Huang, B. C. (2005). Development of a phage displayed disulfide-stabilized Fv fragment vaccine against Vibrio anguillarum. Vaccine 23, 3174-3180. doi: 10.1016/j.vaccine.2004.12.018
233. Xue, H., Xu, Y., Boucher, Y., and Polz, M. F. (2012). High frequency of a novel filamentous phage, VCYϕ, within an environmental Vibrio cholerae population. Appl. Environ. Microbiol. 78, 28-33. doi: 10.1128/AEM.06297-1
234. Yacoby, I., Shamis, M., Bar, H., Shabat, D., and Benhar, I. (2006). Targeting antibacterial agents by using drug-carrying filamentous bacteriophages. Antimicrob. Agents Chemother. 50, 2087-2097. doi: 10.1128/AAC.00169-6
235. Yamada, T. (2013). Filamentous phages of Ralstonia solanacearum: double-edged swords for pathogenic bacteria. Front. Microbiol. 4:325. doi: 10.3389/fmicb.2013.00325
236. Yang, Q., Wang, L., Lu, D. N., Gao, R. J., Song, J. N., Hua, P. Y., et al. (2005a). Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice. Vaccine 23, 4088-4096. doi: 10.1016/j.vaccine.2004.07.005
237. Yang, W. J., Lai, J. F., Peng, K. C., Chiang, H. J., Weng, C. N., and Shiuan, D. (2005b). Epitope mapping of Mycoplasma hyopneumoniae using phage displayed peptide libraries and the immune responses of the selected phagotopes. J. Immunol. Methods 304, 15-29. doi: 10.1016/j.jim.2005.05.009
238. Yi, H., Ghosh, D., Ham, M. H., Qi, J., Barone, P. W., Strano, M. S., et al. (2012). M13 phage-functionalized single-walled carbon nanotubes as nanoprobes for second near-infrared window fluorescence imaging of targeted tumors. Nano Lett. 12, 1176-1183. doi: 10.1021/nl2031663
239. Yip, Y. L., Smith, G., and Ward, R. L. (2001). Comparison of phage pIII, pVIII and GST as carrier proteins for peptide immunisation in Balb/c mice. Immunol. Lett. 79, 197-202. doi: 10.1016/S0165-2478(01)00281-4
240. Yoo, P. J., Nam, K. T., Qi, J., Lee, S. K., Park, J., Belcher, A. M., et al. (2006). Spontaneous assembly of viruses on multilayered polymer surfaces. Nat. Mater. 5, 234-240. doi: 10.1038/nmat1596
241. Yu, M. W., Scott, J. K., Fournier, A., and Talbot, P. J. (2000). Characterization of murine coronavirus neutralization epitopes with phage-displayed peptides. Virology 271, 182-196. doi: 10.1006/viro.2000.0310
242. Zakharova, M. Y., Kozyr, A. V., Ignatova, A. N., Vinnikov, I. A., Shemyakin, I. G., and Kolesnikov, A. V. (2005). Purification of filamentous bacteriophage for phage display using size-exclusion chromatography. Biotechniques 38:194. doi: 10.2144/05382BM04
243. Zhong, G., Smith, G. P., Berry, J., and Brunham, R. C. (1994). Conformational mimicry of a chlamydial neutralization epitope on filamentous phage. J. Biol. Chem. 269, 24183-24188.
244. Zinder, N. D., Valentine, R. C., Roger, M., and Stoeckenius, W. (1963). f1, a rod-shaped male-specific bacteriophage that contains DNA. Virology 20, 638-640. doi: 10.1016/0042-6822(63)90290-3
245. Zou, J., Dickerson, M. T., Owen, N. K., Landon, L. A., and Deutscher, S. L. (2004). Biodistribution of filamentous phage peptide libraries in mice. Mol. Biol. Rep. 31, 121-129. doi: 10.1023/B:MOLE.0000031459.14448.af